Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 21.96
+0.86 (4.08%)
At close: Jul 3, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 11.16 billion as of July 2, 2026. Its market cap has decreased by -15.05% in one year.
Market Cap
11.16B
Enterprise Value
11.01B
Revenue
679.75M
Ranking
n/a
PE Ratio
434.77
Stock Price
21.96
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 11.16B, an increase of 35.12%. That is a compound annual growth rate of 7.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 11.16B | -9.10% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 12.33B |
| Guobang Pharma | 12.33B |
| Zhejiang Hisun Pharmaceutical | 12.20B |
| Shanghai Shyndec Pharmaceutical | 11.96B |
| Zhejiang Garden Biopharmaceutical | 11.83B |
| Henan Lingrui Pharmaceutical | 11.67B |
| Zhejiang Medicine | 11.65B |
| Hubei Hongyuan Pharmaceutical Technology | 10.67B |